Cytokine gene polymorphisms are associated with risk of urinary bladder cancer and recurrence after BCG immunotherapy. (Q47671800)

4 February 2018

title

Cytokine gene polymorphisms are associated with risk of urinary bladder cancer and recurrence after BCG immunotherapy. (English)

1 reference

4 February 2018

1 reference

1 reference

Dinesh K Ahirwar

1

1 reference

4 February 2018

Anita Agrahari

series ordinal

2

1 reference

4 February 2018

Anil Mandhani

series ordinal

3

1 reference

4 February 2018

Rama D Mittal

series ordinal

4

1 reference

4 February 2018

publication date

1 June 2009

1 reference

4 February 2018

published in

Biomarkers

1 reference

4 February 2018

volume

14

1 reference

4 February 2018

issue

4

1 reference

4 February 2018

page(s)

213-218

1 reference

4 February 2018

The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13547500902818246

Cytokine gene polymorphisms can alter the effect of Bacillus Calmette-Guérin (BCG) immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902818246

Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902818246

MIC1 and IL1RN genetic variation and advanced prostate cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902818246

Role of Th1 and Th2 cytokines in BCG-induced IFN-gamma production: cytokine promotion and simulation of BCG effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902818246

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902818246

A simple salting out procedure for extracting DNA from human nucleated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902818246

XRCC1 codon 399 mutant allele: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902818246

Tumorigenicity of IL-1alpha- and IL-1beta-deficient fibrosarcoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902818246

Advances in the management of superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902818246

Urinary cytokines reflecting the immunological response in the urinary bladder to biological response modifiers: their practical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902818246

DNA methylation-associated inactivation of TGFbeta-related genes DRM/Gremlin, RUNX3, and HPP1 in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902818246

Potential influence of interleukin-1 haplotype IL-1 beta-511*T-IL-1RN*1 in conferring low risk to middle third location of esophageal cancer: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902818246

Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902818246

10.1080/13547500902818246

21 January 2018

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

19489682

1 reference

4 February 2018